Leukemia Clinical Trials

A listing of Leukemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 476 clinical trials
Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation

after a stem cell transplant. Researchers also want to learn if inotuzumab ozogamicin when given after a stem cell transplant can help control leukemia and lymphoma. Inotuzumab ozogamicin is a

bone marrow procedure
antithymocyte globulin
lymphoma
carbon monoxide
allogeneic bone marrow transplantation
  • 2 views
  • 21 Apr, 2022
  • 1 location
A Study of E7820 in People With Bone Marrow (Myeloid) Cancers

will have acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), or chronic myelomonocytic leukemia (CMML).

lenalidomide
refractory acute myeloid leukemia (aml)
leukemia
induction chemotherapy
IDH2
  • 0 views
  • 17 May, 2022
  • 7 locations
PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCT (PTCyRuxo)

This is multicenter investigator-initiated randomized open-label phase II clinical trial to compare prophylaxis of graft versus host disease treated with tacrolimus and mycophenolate mofetil versus ruxolitinib after post-transplant cyclophosphamide. In total 128 patients will be included in the study. After inclusion into the study and performing of transplantation patients will …

cyclophosphamide
flow cytometry
mycophenolate mofetil
graft versus host disease
remission
  • 0 views
  • 19 Apr, 2022
  • 2 locations
CLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic Malignancies (CLIC-01)

) cells for participants with relapsed/refractory CD19 positive (CD19+) Acute Lymphoblastic Leukemia (ALL) and non-Hodgkin's Lymphoma (NHL). The Initial Stage of the study (n=20 participants) will focus

diffuse large b-cell lymphoma
follicular lymphoma
salvage therapy
lymphoma
cell transplantation
  • 12 views
  • 18 Apr, 2022
  • 2 locations
Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation

This phase II trial studies how well enasidenib and azacitidine work in treating patients with IDH2 gene mutation and acute myeloid leukemia that has come back (recurrent) or does not respond to

leukemia
refractory acute myeloid leukemia (aml)
IDH2
myelomonocytic leukemia
enasidenib
  • 13 views
  • 28 May, 2022
  • 1 location
A Study of ASTX030 (Cedazuridine in Combination With Azacitidine) in MDS, CMML, or AML

Study ASTX030-01 is designed to move efficiently from Phase 1 to Phase 3. Phase 1 consists of an open-label Dose Escalation Stage (Stage A) using multiple cohorts at escalating dose levels of oral cedazuridine and azacitidine (only one study drug will be escalated at a time) followed by a Dose …

bone marrow procedure
graft versus host disease
anemia
chronic myelomonocytic leukemia
conjugated bilirubin
  • 0 views
  • 30 Apr, 2022
  • 4 locations
ASTX727, Venetoclax, and Gilteritinib for the Treatment of Newly Diagnosed, Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

-mutated acute myeloid leukemia that is newly diagnosed, has come back (relapsed) or does not respond to treatment (refractory) or high-risk myelodysplastic syndrome. Chemotherapy drugs, such as ASTX727

hydroxyurea
leukemia
myeloid leukemia
carbon monoxide
serum bilirubin level
  • 0 views
  • 09 May, 2022
  • 1 location
Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation

This phase II trial studies how well olaparib works in treating patients with acute myeloid leukemia that has come back (relapsed) or does not respond to treatment (refractory), or

hysterectomy
hematologic malignancy
hematologic disorder
cancer
blast cells
  • 0 views
  • 16 May, 2022
  • 4 locations
Ruxolitinib and Venetoclax in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

This phase I trial studies the side effects and best dose of ruxolitinib when given together with venetoclax in treating patients with acute myeloid leukemia that has come back (relapsed) or has

ejection fraction
refractory acute myeloid leukemia (aml)
leukemia
ruxolitinib
hydroxyurea
  • 5 views
  • 11 Apr, 2022
  • 2 locations
Daratumumab and Ibrutinib for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia, DIRECT Study

This phase II trial studies how well daratumumab and ibrutinib work in treating patients with chronic lymphocytic leukemia that has come back (relapsed) or has not responded to previous

leukemia
refractory chronic lymphocytic leukemia
flow cytometry
chronic lymphocytic leukemia
direct bilirubin
  • 0 views
  • 14 Apr, 2022
  • 1 location